TREM2 and Alzheimer disease: In addition, a biomarker analysis of healthy elderly, MCI patients, and AD patients has found that MCI patients with low levels of TREM2 in CSF or high levels of plasma TREM2 are more likely to accelerate the progression of AD [71].